Fuan Pharmaceutical Group Co Financial Flexibility Index
Fuan Pharmaceutical Group Co financial flexibility index. Fuan Pharmaceutical Group Co (300194) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥123.08 Million (operating CF CN¥100.27 Million minus capex CN¥22.81 Million) represents 0% of total liabilities (CN¥1.51 Billion). See Fuan Pharmaceutical Group Co (300194) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Fuan Pharmaceutical Group Co (2007–2025)
Financial flexibility index of Fuan Pharmaceutical Group Co from 2007 to 2025. Historical Financial Flexibility Index trend for Fuan Pharmaceutical Group Co across 19 annual periods. Check 300194 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Fuan Pharmaceutical Group Co Financial Flexibility Index by Year (2007–2025)
Fuan Pharmaceutical Group Co financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Fuan Pharmaceutical Group Co. For the full cash flow conversion analysis, see Fuan Pharmaceutical Group Co operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | CN¥420.76 Million | CN¥312.32 Million | CN¥1.40 Billion | ▼ -12.8% |
| 2024 | 0.35x | CN¥545.38 Million | CN¥303.59 Million | CN¥1.58 Billion | ▲ +15.8% |
| 2023 | 0.30x | CN¥544.66 Million | CN¥328.98 Million | CN¥1.83 Billion | ▼ -20.3% |
| 2022 | 0.37x | CN¥722.60 Million | CN¥339.50 Million | CN¥1.93 Billion | ▲ +2.7% |
| 2021 | 0.36x | CN¥670.16 Million | CN¥257.13 Million | CN¥1.84 Billion | ▲ +1.8% |
| 2020 | 0.36x | CN¥507.09 Million | CN¥162.55 Million | CN¥1.42 Billion | ▼ -48.6% |
| 2019 | 0.70x | CN¥519.42 Million | CN¥295.63 Million | CN¥746.59 Million | ▲ +4.2% |
| 2018 | 0.67x | CN¥399.84 Million | CN¥267.68 Million | CN¥598.62 Million | ▼ -35.7% |
| 2017 | 1.04x | CN¥537.99 Million | CN¥453.37 Million | CN¥518.24 Million | ▼ -14.7% |
| 2016 | 1.22x | CN¥528.08 Million | CN¥374.16 Million | CN¥434.00 Million | ▲ +64.8% |
| 2015 | 0.74x | CN¥253.19 Million | CN¥161.03 Million | CN¥342.91 Million | ▲ +283.1% |
| 2014 | 0.19x | CN¥24.03 Million | CN¥-31.27 Million | CN¥124.69 Million | ▼ -89.8% |
| 2013 | 1.89x | CN¥261.58 Million | CN¥89.61 Million | CN¥138.47 Million | ▼ -18.5% |
| 2012 | 2.32x | CN¥195.21 Million | CN¥62.77 Million | CN¥84.20 Million | ▲ +74.4% |
| 2011 | 1.33x | CN¥165.78 Million | CN¥64.85 Million | CN¥124.69 Million | ▼ -50.4% |
| 2010 | 2.68x | CN¥174.48 Million | CN¥105.74 Million | CN¥65.09 Million | ▲ +215.3% |
| 2009 | 0.85x | CN¥93.79 Million | CN¥62.75 Million | CN¥110.31 Million | ▼ -6.7% |
| 2008 | 0.91x | CN¥83.71 Million | CN¥49.23 Million | CN¥91.83 Million | ▲ +97.5% |
| 2007 | 0.46x | CN¥33.50 Million | CN¥18.92 Million | CN¥72.58 Million | — |